Chinese Wilds

About Chinese Wilds

The upcoming indie biopic, titled The Chop, is being written and produced by filmmaker, writer, and stand-up comedian Mike Young through Red Leaf Entertainment. Production is targeted for 2027, though no director, cast, or financing details have been announced.

According to the film’s synopsis, the story traces Morrow as he connects with a group of gamblers whose high-stakes approach to risk begins attracting serious attention on casino floors across Las Vegas. As their reputation grows, Morrow is pushed further into the spotlight, confronting new pressures involving ambition, family, and fame.

Vegas Matt made headlines recently after claiming that The Venetian escorted him off its property after he won a $400,000 jackpot on a Phoenix Link slot machine—a story that fueled widespread debate over how major resorts manage high-profile casino influencers on their gaming floors.

About Chinese Wilds

“We continue to view regulation as the largest risk to prediction markets,” says the analyst. “While industry growth remains robust, adverse legal outcomes could materially impact sports contract availability and long-term adoption.”

Amid a string of losses in federal appellate courts, it appears increasingly prediction markets are angling to take their cases to the U.S. Supreme Court, banking that the high court will allow them to continue offering sports event contracts free of state gambling regulations.

Some legal experts and members of the investment community believe it’s possible the Supreme Court could hear a prediction market case at some point over the next six or seven months.

What is Chinese Wilds?

Under the terms of the agreement, Merkur will acquire 95% of Casigrangi, while DOFA will retain a 5% interest, subject to reciprocal put and call options exercisable in the future.

Casigrangi currently holds approximately 4,135,434 shares in SFC, amounting to 81.2% of its capital and voting rights based on figures from 31 October 2025.

Merkur has agreed to pay an effective price of €6.19 per SFC share for the stake, representing a substantial premium over recent market valuations.